Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005783 | endoplasmic reticulum | 5 | 2 |
GO:0005789 | endoplasmic reticulum membrane | 4 | 12 |
GO:0016020 | membrane | 2 | 12 |
GO:0031090 | organelle membrane | 3 | 12 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: E9AFC7
Term | Name | Level | Count |
---|---|---|---|
GO:0006479 | protein methylation | 4 | 2 |
GO:0006481 | C-terminal protein methylation | 5 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0008213 | protein alkylation | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0018410 | C-terminal protein amino acid modification | 6 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0032259 | methylation | 2 | 2 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043414 | macromolecule methylation | 3 | 2 |
GO:0043687 | post-translational protein modification | 5 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity | 5 | 12 |
GO:0004671 | protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity | 6 | 12 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0008171 | O-methyltransferase activity | 5 | 12 |
GO:0008276 | protein methyltransferase activity | 3 | 12 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 12 |
GO:0010340 | carboxyl-O-methyltransferase activity | 6 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0051998 | protein carboxyl O-methyltransferase activity | 4 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 56 | 60 | PF00656 | 0.286 |
CLV_C14_Caspase3-7 | 91 | 95 | PF00656 | 0.517 |
CLV_NRD_NRD_1 | 18 | 20 | PF00675 | 0.387 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.366 |
CLV_PCSK_SKI1_1 | 132 | 136 | PF00082 | 0.228 |
DOC_CDC14_PxL_1 | 99 | 107 | PF14671 | 0.468 |
DOC_CYCLIN_RxL_1 | 22 | 32 | PF00134 | 0.571 |
DOC_CYCLIN_yCln2_LP_2 | 195 | 201 | PF00134 | 0.217 |
DOC_CYCLIN_yCln2_LP_2 | 214 | 220 | PF00134 | 0.158 |
DOC_MAPK_gen_1 | 253 | 263 | PF00069 | 0.443 |
DOC_MAPK_MEF2A_6 | 256 | 265 | PF00069 | 0.456 |
DOC_PP4_FxxP_1 | 85 | 88 | PF00568 | 0.523 |
LIG_14-3-3_CanoR_1 | 141 | 150 | PF00244 | 0.242 |
LIG_14-3-3_CanoR_1 | 161 | 166 | PF00244 | 0.166 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.698 |
LIG_BRCT_BRCA1_1 | 145 | 149 | PF00533 | 0.336 |
LIG_EH1_1 | 254 | 262 | PF00400 | 0.448 |
LIG_FHA_1 | 108 | 114 | PF00498 | 0.525 |
LIG_FHA_1 | 143 | 149 | PF00498 | 0.313 |
LIG_FHA_1 | 186 | 192 | PF00498 | 0.250 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.316 |
LIG_FHA_2 | 54 | 60 | PF00498 | 0.309 |
LIG_FHA_2 | 89 | 95 | PF00498 | 0.490 |
LIG_LIR_Apic_2 | 118 | 123 | PF02991 | 0.501 |
LIG_LIR_Gen_1 | 170 | 176 | PF02991 | 0.262 |
LIG_LIR_Gen_1 | 94 | 104 | PF02991 | 0.512 |
LIG_LIR_Nem_3 | 146 | 152 | PF02991 | 0.253 |
LIG_LIR_Nem_3 | 227 | 231 | PF02991 | 0.450 |
LIG_LIR_Nem_3 | 250 | 255 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 94 | 99 | PF02991 | 0.488 |
LIG_Pex14_2 | 201 | 205 | PF04695 | 0.207 |
LIG_REV1ctd_RIR_1 | 136 | 145 | PF16727 | 0.509 |
LIG_REV1ctd_RIR_1 | 228 | 238 | PF16727 | 0.407 |
LIG_SH2_CRK | 192 | 196 | PF00017 | 0.235 |
LIG_SH2_NCK_1 | 120 | 124 | PF00017 | 0.594 |
LIG_SH2_STAP1 | 144 | 148 | PF00017 | 0.272 |
LIG_SH2_STAP1 | 237 | 241 | PF00017 | 0.386 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.484 |
LIG_SH2_STAT5 | 144 | 147 | PF00017 | 0.299 |
LIG_SH2_STAT5 | 194 | 197 | PF00017 | 0.239 |
LIG_SH2_STAT5 | 200 | 203 | PF00017 | 0.206 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.510 |
LIG_SH2_STAT5 | 247 | 250 | PF00017 | 0.394 |
LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.288 |
LIG_SH3_3 | 258 | 264 | PF00018 | 0.462 |
LIG_SUMO_SIM_anti_2 | 151 | 157 | PF11976 | 0.329 |
LIG_TRAF2_1 | 236 | 239 | PF00917 | 0.411 |
MOD_CK1_1 | 170 | 176 | PF00069 | 0.258 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.628 |
MOD_CK2_1 | 2 | 8 | PF00069 | 0.562 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.281 |
MOD_GlcNHglycan | 145 | 148 | PF01048 | 0.407 |
MOD_GlcNHglycan | 181 | 184 | PF01048 | 0.528 |
MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.320 |
MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.390 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.514 |
MOD_N-GLC_1 | 142 | 147 | PF02516 | 0.233 |
MOD_N-GLC_1 | 170 | 175 | PF02516 | 0.407 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.631 |
MOD_NEK2_1 | 105 | 110 | PF00069 | 0.474 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.313 |
MOD_NEK2_1 | 204 | 209 | PF00069 | 0.230 |
MOD_NEK2_1 | 230 | 235 | PF00069 | 0.499 |
MOD_PKA_2 | 179 | 185 | PF00069 | 0.219 |
MOD_PKA_2 | 88 | 94 | PF00069 | 0.433 |
MOD_Plk_1 | 170 | 176 | PF00069 | 0.207 |
MOD_Plk_1 | 237 | 243 | PF00069 | 0.447 |
MOD_Plk_4 | 161 | 167 | PF00069 | 0.324 |
MOD_Plk_4 | 221 | 227 | PF00069 | 0.326 |
TRG_ENDOCYTIC_2 | 192 | 195 | PF00928 | 0.239 |
TRG_ER_diArg_1 | 17 | 19 | PF00400 | 0.630 |
TRG_ER_diArg_1 | 231 | 234 | PF00400 | 0.512 |
TRG_Pf-PMV_PEXEL_1 | 26 | 31 | PF00026 | 0.274 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P511 | Leptomonas seymouri | 65% | 100% |
A0A0S4JHW1 | Bodo saltans | 45% | 100% |
A0A1X0P5F1 | Trypanosomatidae | 51% | 100% |
A0A3S7X9G8 | Leishmania donovani | 93% | 100% |
A0A422P2Y4 | Trypanosoma rangeli | 50% | 100% |
A2XX73 | Oryza sativa subsp. indica | 34% | 100% |
A4HMX0 | Leishmania braziliensis | 83% | 100% |
A4IBJ1 | Leishmania infantum | 93% | 100% |
C9ZZ50 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
D6WJ77 | Tribolium castaneum | 34% | 95% |
E9B6I2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
O12947 | Xenopus laevis | 31% | 92% |
O60725 | Homo sapiens | 30% | 94% |
P32584 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 31% | 100% |
P87014 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 35% | 100% |
Q558K8 | Dictyostelium discoideum | 33% | 100% |
Q7XSR9 | Oryza sativa subsp. japonica | 34% | 100% |
Q9EQK7 | Mus musculus | 32% | 94% |
Q9WVM4 | Rattus norvegicus | 32% | 94% |
V5C2X9 | Trypanosoma cruzi | 48% | 100% |